Blue Horseshoe Stocks: MU Recap & More

Micron Technology, Inc. MU

On Friday morning we spent most of our report updating readers on several great stock calls we’ve made in recent weeks, but we did include one fresh options trading idea, and we’re pleased to report that it was a resounding success, and a greta opportunity to daytraders to nail down some quick profits.

We targeted the MU Weekly $43-45 Calls and the whole range took off for the following impressive single-session gains:

$43 Calls – Range: .97-2.50 – Max Gain: 158%
$43.50 Calls – Range: .68-2.05 – Max Gain: 201%
$44 Calls – Range: .32-1.50 – Max Gain: 369%
$44.50 Calls – Range: .17-1.07 – Max Gain: 529%
$45 Calls – Range: .08-.68 – Max Gain: 750%

Our quick-strike options prowess has been second to none for quite some time now, and MU was another shining example of that! Big cheers to anyone who was able to take advantage.
_____

Adobe Systems, Inc. ADBE – Fresh Options Idea

For a fresh idea, we’re going to signal a longer-term set of contracts in the ADBE chain. The stock has a fairly predictable trading pattern, and appears to be approaching an up-cycle in the days or weeks ahead.

If we can see ADBE maintain support at or above 258.49, we are going to be very interested in the ADBE 10/26 $260-265 Calls.



Cool Holdings. Inc. AWSM

 
Also in Friday morning’s report was a tag of AWSM. We had just noticed it’s big day in the prior session, and included it in our daily watchlist.

The stock made an absolutely monstrous single-session run for something trading in the $11-range, running from a low of 11.11 to a high of 22.61 for a 104% intraday move. It also closed more than 80% in the green on the day!


Extended Watchlist: 
AMMA, AGRX, BPMX, TEUM, ONTX, ABX, SENS, GLOW, PDLI

Incoming search terms:

  • best penny stocks

Blue Horseshoe Stocks: AYTU Update & More

Aytu BioScience, Inc. AYTU Yesterday morning, we were just discussing AYTU and the modest progress the stock had made since we flagged it as a bottom play in Wednesday’s premarket report. Not only had it displayed a cherry bottom setup, but we noted a string of insider buysat the time as well.Following that report, we would witness a low of .4118, and over the course of the ensuing four trading days, the stock has made a noteworthy move and continues to exhibit signs that more gains could be in store.

Yesterday it reached .61, which represents a run of 48% in under a week. It did so on record volume, so we’re definitely eager to see where the momentum could carry this play that was already on its way back up.


InspireMD, Inc. NSPR

NSPR has been in real trouble in 2018, losing ground at seemingly every turn and unable to get out of its own way. However, through a combination of a South American breakthrough announcement for two of the companies drugs, and being just plain oversold, we’re seeing a marginal premarket gap-up and will want to observe for a more sustained rebound.

The news was pertaining to NSPR receiving regulatory approval from the goverment of Peru for its CGuard™ Embolic Prevention System (EPS) and MGuard Prime™ products. Peru has a population of more than 30 million people. (>>View PR)


Extended Watchlist:
ARWR, GLOW, MDGS, MBRX, SEE, WBAI, LIQT, PIXY,